causal

Manufacturing, Not Regulation, Is the Real Barrier

The barrier to entry in CGMs is mainly technology and manufacturing rather than regulatory approval, since the latest generation was cleared through the relatively easier 510(k) pathway.

causalpending

Speaker

Aneal

Evidence Quote

“The latest generation was approved under a 510pathway is much easier. I view the barriers to entry as actually much more focused on technology in manufacturing component.”

Source

Dexcom: Digitizing Diabetes Management— Business Breakdowns
Created: 11/20/2026, 5:18:27 AM

Your notes

Loading notes...